Basal Cell Carcinoma News and Research

RSS
Basal cell cancer begins in the lowest layer of the epidermis, the basal cell layer. About 8 out of 10 skin cancers are basal cell carcinomas. They usually begin on areas exposed to the sun, such as the head and neck. Basal cell carcinoma was once found mostly in middle-aged or older people. But now it is also being seen in younger people. This may be because people are spending more time in the sun without protecting their skin.

Basal cell carcinoma tends to grow slowly. It is very rare for a basal cell cancer to spread to distant parts of the body (metastasize). But if it is not treated, it can grow into nearby areas and spread into the bone or other tissues beneath the skin.

After treatment, basal cell carcinoma can come back (recur) in the same place on the skin. New basal cell cancers can also start in other places on the skin. As many as half of the people who have one basal cell cancer will get a new skin cancer within 5 years.
New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

Michelson Diagnostics’ VivoSight OCT scanner provides accurate diagnosis of early-stage BCC, reduces skin biopsies by 36%

Michelson Diagnostics’ VivoSight OCT scanner provides accurate diagnosis of early-stage BCC, reduces skin biopsies by 36%

Roflumilast drug could inhibit growth of brain tumor in children

Roflumilast drug could inhibit growth of brain tumor in children

HPPI commences enrollment for Phase II(b) SCORING clinical trial for cancer treatment

HPPI commences enrollment for Phase II(b) SCORING clinical trial for cancer treatment

Vismodegib therapy effective against medulloblastoma

Vismodegib therapy effective against medulloblastoma

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

New understanding of keratin 17 protein could lead to development of better ways to prevent cancer

New understanding of keratin 17 protein could lead to development of better ways to prevent cancer

Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma

Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma

Skin Cancer Awareness Recommended For HCT Recipients

Skin Cancer Awareness Recommended For HCT Recipients

New laser technology shows promise for cancer treatment

New laser technology shows promise for cancer treatment

Scientists potentially discover new therapeutic targets to halt progression of tumor cells

Scientists potentially discover new therapeutic targets to halt progression of tumor cells

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Exposure to ultraviolet radiation lamps used for indoor tanning increases risk of developing BCC

Exposure to ultraviolet radiation lamps used for indoor tanning increases risk of developing BCC

EU-funded project aims to identify potential new targets for cancer therapy

EU-funded project aims to identify potential new targets for cancer therapy

Novartis LDE225 Phase II study for advanced basal cell carcinoma meets primary endpoint

Novartis LDE225 Phase II study for advanced basal cell carcinoma meets primary endpoint

Study to investigate use of OCT in collaboration with Melanoma Institute of Australia

Study to investigate use of OCT in collaboration with Melanoma Institute of Australia

Skin Cancer Awareness Month and Melanoma Monday: Mount Sinai experts to share vital skin cancer tips

Skin Cancer Awareness Month and Melanoma Monday: Mount Sinai experts to share vital skin cancer tips

Curis and Debiopharm present data for Debio 0932 at Annual Meeting of AACR

Curis and Debiopharm present data for Debio 0932 at Annual Meeting of AACR

Ascend Biopharmaceuticals reports favourable results from TG1042 Phase 2 study for CBCL treatment

Ascend Biopharmaceuticals reports favourable results from TG1042 Phase 2 study for CBCL treatment

Study provides extensive review of incidence, risk factors and characteristics of skin cancer in people of color

Study provides extensive review of incidence, risk factors and characteristics of skin cancer in people of color